Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion

Identifieur interne : 001377 ( Ncbi/Merge ); précédent : 001376; suivant : 001378

Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion

Auteurs : Jesse Bodle ; Erin E. Verity ; Chi Ong ; Kirsten Vandenberg ; Robert Shaw ; Ian G. Barr ; Steven Rockman

Source :

RBID : PMC:5780761

Descripteurs français

English descriptors

Abstract

Please cite this paper as: Bodle et al. (2013) Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza and Other Respiratory Viruses 7(2) 191–200.

Background  The current method used to measure haemagglutinin (HA) content for influenza vaccine formulation, single radial immunodiffusion (SRID), is lengthy and relies on the availability of matched standardised homologous reagents. The 2009 influenza pandemic highlighted the need to develop alternate assays that are able to rapidly quantitate HA antigen for vaccine formulation.

Objectives  The aim of this work was to develop an enzyme‐linked immunoassay (EIA) for the rapid quantitation of H1, H3, H5 and B influenza HA antigens.

Methods  Monoclonal antibodies (mAbs) selected for haemagglutination inhibition (HAI) activity were conjugated with horseradish peroxidase and used to establish a capture–detection EIA for the quantitation of HA antigen. Results were compared with the appropriate reference SRID assays to investigate assay performance and utility.

Results  Quantitation of HA antigen by EIA correlated well with current reference SRID assays. EIA results showed equivalent precision and exhibited a similar capacity to detect HA antigen in virus samples that had been used in either stability or splitting studies, or subjected to physical or chemical stresses. EIA exhibited greater sensitivity than SRID and has the potential to be used in high‐throughput applications.

Conclusions  We demonstrated the utility of EIA as a suitable alternative to SRID for HA antigen quantitation and stability assessment. This approach would lead to earlier availability of both seasonal and pandemic vaccines, because of the extended cross‐reactivity of reagents.


Url:
DOI: 10.1111/j.1750-2659.2012.00375.x
PubMed: 22583601
PubMed Central: 5780761

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:5780761

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E." last="Verity">Erin E. Verity</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G." last="Barr">Ian G. Barr</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22583601</idno>
<idno type="pmc">5780761</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780761</idno>
<idno type="RBID">PMC:5780761</idno>
<idno type="doi">10.1111/j.1750-2659.2012.00375.x</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000A67</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000A67</idno>
<idno type="wicri:Area/Pmc/Curation">000A67</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000A67</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000746</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000746</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:22583601</idno>
<idno type="wicri:Area/PubMed/Corpus">000C95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C95</idno>
<idno type="wicri:Area/PubMed/Curation">000C95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C95</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A44</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A44</idno>
<idno type="wicri:Area/Ncbi/Merge">001377</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E." last="Verity">Erin E. Verity</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G." last="Barr">Ian G. Barr</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Influenza and Other Respiratory Viruses</title>
<idno type="ISSN">1750-2640</idno>
<idno type="eISSN">1750-2659</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Monoclonal (isolation & purification)</term>
<term>Enzyme-Linked Immunosorbent Assay (methods)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (analysis)</term>
<term>Horseradish Peroxidase (metabolism)</term>
<term>Humans</term>
<term>Immunodiffusion (methods)</term>
<term>Influenza Vaccines (chemistry)</term>
<term>Influenza Vaccines (standards)</term>
<term>Technology, Pharmaceutical (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticorps monoclonaux (isolement et purification)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (analyse)</term>
<term>Horseradish peroxidase (métabolisme)</term>
<term>Humains</term>
<term>Immunodiffusion ()</term>
<term>Technologie pharmaceutique ()</term>
<term>Test ELISA ()</term>
<term>Vaccins antigrippaux ()</term>
<term>Vaccins antigrippaux (normes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>Antibodies, Monoclonal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Horseradish Peroxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Glycoprotéine hémagglutinine du virus influenza</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Anticorps monoclonaux</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Immunodiffusion</term>
<term>Technology, Pharmaceutical</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Horseradish peroxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Immunodiffusion</term>
<term>Technologie pharmaceutique</term>
<term>Test ELISA</term>
<term>Vaccins antigrippaux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<italic>Please cite this paper as:</italic>
Bodle
<italic>et al.</italic>
(2013) Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza and Other Respiratory Viruses 7(2) 191–200.</p>
<p>
<bold>Background </bold>
The current method used to measure haemagglutinin (HA) content for influenza vaccine formulation, single radial immunodiffusion (SRID), is lengthy and relies on the availability of matched standardised homologous reagents. The 2009 influenza pandemic highlighted the need to develop alternate assays that are able to rapidly quantitate HA antigen for vaccine formulation.</p>
<p>
<bold>Objectives </bold>
The aim of this work was to develop an enzyme‐linked immunoassay (EIA) for the rapid quantitation of H1, H3, H5 and B influenza HA antigens.</p>
<p>
<bold>Methods </bold>
Monoclonal antibodies (mAbs) selected for haemagglutination inhibition (HAI) activity were conjugated with horseradish peroxidase and used to establish a capture–detection EIA for the quantitation of HA antigen. Results were compared with the appropriate reference SRID assays to investigate assay performance and utility.</p>
<p>
<bold>Results </bold>
Quantitation of HA antigen by EIA correlated well with current reference SRID assays. EIA results showed equivalent precision and exhibited a similar capacity to detect HA antigen in virus samples that had been used in either stability or splitting studies, or subjected to physical or chemical stresses. EIA exhibited greater sensitivity than SRID and has the potential to be used in high‐throughput applications.</p>
<p>
<bold>Conclusions </bold>
We demonstrated the utility of EIA as a suitable alternative to SRID for HA antigen quantitation and stability assessment. This approach would lead to earlier availability of both seasonal and pandemic vaccines, because of the extended cross‐reactivity of reagents.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lenette, E" uniqKey="Lenette E">E Lenette</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<double pmid="22583601">
<pmc>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E." last="Verity">Erin E. Verity</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G." last="Barr">Ian G. Barr</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22583601</idno>
<idno type="pmc">5780761</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780761</idno>
<idno type="RBID">PMC:5780761</idno>
<idno type="doi">10.1111/j.1750-2659.2012.00375.x</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000A67</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000A67</idno>
<idno type="wicri:Area/Pmc/Curation">000A67</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000A67</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000746</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000746</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E." last="Verity">Erin E. Verity</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G." last="Barr">Ian G. Barr</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Influenza and Other Respiratory Viruses</title>
<idno type="ISSN">1750-2640</idno>
<idno type="eISSN">1750-2659</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<italic>Please cite this paper as:</italic>
Bodle
<italic>et al.</italic>
(2013) Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza and Other Respiratory Viruses 7(2) 191–200.</p>
<p>
<bold>Background </bold>
The current method used to measure haemagglutinin (HA) content for influenza vaccine formulation, single radial immunodiffusion (SRID), is lengthy and relies on the availability of matched standardised homologous reagents. The 2009 influenza pandemic highlighted the need to develop alternate assays that are able to rapidly quantitate HA antigen for vaccine formulation.</p>
<p>
<bold>Objectives </bold>
The aim of this work was to develop an enzyme‐linked immunoassay (EIA) for the rapid quantitation of H1, H3, H5 and B influenza HA antigens.</p>
<p>
<bold>Methods </bold>
Monoclonal antibodies (mAbs) selected for haemagglutination inhibition (HAI) activity were conjugated with horseradish peroxidase and used to establish a capture–detection EIA for the quantitation of HA antigen. Results were compared with the appropriate reference SRID assays to investigate assay performance and utility.</p>
<p>
<bold>Results </bold>
Quantitation of HA antigen by EIA correlated well with current reference SRID assays. EIA results showed equivalent precision and exhibited a similar capacity to detect HA antigen in virus samples that had been used in either stability or splitting studies, or subjected to physical or chemical stresses. EIA exhibited greater sensitivity than SRID and has the potential to be used in high‐throughput applications.</p>
<p>
<bold>Conclusions </bold>
We demonstrated the utility of EIA as a suitable alternative to SRID for HA antigen quantitation and stability assessment. This approach would lead to earlier availability of both seasonal and pandemic vaccines, because of the extended cross‐reactivity of reagents.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lenette, E" uniqKey="Lenette E">E Lenette</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</pmc>
<pubmed>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation wicri:level="1">
<nlm:affiliation>CSL Ltd, Parkville, Vic., Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CSL Ltd, Parkville, Vic.</wicri:regionArea>
<wicri:noRegion>Vic.</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E" last="Verity">Erin E. Verity</name>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G" last="Barr">Ian G. Barr</name>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:22583601</idno>
<idno type="pmid">22583601</idno>
<idno type="doi">10.1111/j.1750-2659.2012.00375.x</idno>
<idno type="wicri:Area/PubMed/Corpus">000C95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C95</idno>
<idno type="wicri:Area/PubMed/Curation">000C95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C95</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A44</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A44</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.</title>
<author>
<name sortKey="Bodle, Jesse" sort="Bodle, Jesse" uniqKey="Bodle J" first="Jesse" last="Bodle">Jesse Bodle</name>
<affiliation wicri:level="1">
<nlm:affiliation>CSL Ltd, Parkville, Vic., Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>CSL Ltd, Parkville, Vic.</wicri:regionArea>
<wicri:noRegion>Vic.</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Verity, Erin E" sort="Verity, Erin E" uniqKey="Verity E" first="Erin E" last="Verity">Erin E. Verity</name>
</author>
<author>
<name sortKey="Ong, Chi" sort="Ong, Chi" uniqKey="Ong C" first="Chi" last="Ong">Chi Ong</name>
</author>
<author>
<name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name>
</author>
<author>
<name sortKey="Shaw, Robert" sort="Shaw, Robert" uniqKey="Shaw R" first="Robert" last="Shaw">Robert Shaw</name>
</author>
<author>
<name sortKey="Barr, Ian G" sort="Barr, Ian G" uniqKey="Barr I" first="Ian G" last="Barr">Ian G. Barr</name>
</author>
<author>
<name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name>
</author>
</analytic>
<series>
<title level="j">Influenza and other respiratory viruses</title>
<idno type="eISSN">1750-2659</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Monoclonal (isolation & purification)</term>
<term>Enzyme-Linked Immunosorbent Assay (methods)</term>
<term>Hemagglutinin Glycoproteins, Influenza Virus (analysis)</term>
<term>Horseradish Peroxidase (metabolism)</term>
<term>Humans</term>
<term>Immunodiffusion (methods)</term>
<term>Influenza Vaccines (chemistry)</term>
<term>Influenza Vaccines (standards)</term>
<term>Technology, Pharmaceutical (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticorps monoclonaux (isolement et purification)</term>
<term>Glycoprotéine hémagglutinine du virus influenza (analyse)</term>
<term>Horseradish peroxidase (métabolisme)</term>
<term>Humains</term>
<term>Immunodiffusion ()</term>
<term>Technologie pharmaceutique ()</term>
<term>Test ELISA ()</term>
<term>Vaccins antigrippaux ()</term>
<term>Vaccins antigrippaux (normes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Hemagglutinin Glycoproteins, Influenza Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>Antibodies, Monoclonal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Horseradish Peroxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Glycoprotéine hémagglutinine du virus influenza</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Anticorps monoclonaux</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Immunodiffusion</term>
<term>Technology, Pharmaceutical</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Horseradish peroxidase</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Immunodiffusion</term>
<term>Technologie pharmaceutique</term>
<term>Test ELISA</term>
<term>Vaccins antigrippaux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The current method used to measure haemagglutinin (HA) content for influenza vaccine formulation, single radial immunodiffusion (SRID), is lengthy and relies on the availability of matched standardised homologous reagents. The 2009 influenza pandemic highlighted the need to develop alternate assays that are able to rapidly quantitate HA antigen for vaccine formulation.</div>
</front>
</TEI>
</pubmed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001377 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001377 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:5780761
   |texte=   Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:22583601" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021